↓ Skip to main content

Cochrane Database of Systematic Reviews

Methylxanthine treatment for apnoea in preterm infants

Overview of attention for article published in Cochrane database of systematic reviews, December 2010
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

blogs
1 blog
twitter
2 X users
wikipedia
1 Wikipedia page

Citations

dimensions_citation
183 Dimensions

Readers on

mendeley
242 Mendeley
connotea
1 Connotea
Title
Methylxanthine treatment for apnoea in preterm infants
Published in
Cochrane database of systematic reviews, December 2010
DOI 10.1002/14651858.cd000140.pub2
Pubmed ID
Authors

David J Henderson‐Smart, Antonio G De Paoli

Abstract

Recurrent apnoea is common in preterm infants, particularly at very early gestational ages. These episodes of ineffective breathing can lead to hypoxaemia and bradycardia that may be severe enough to require the use of positive pressure ventilation. Methylxanthines (such as caffeine, theophylline or aminophylline) have been used to stimulate breathing and reduce apnoea and its consequences.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 242 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 <1%
Indonesia 1 <1%
South Africa 1 <1%
United Kingdom 1 <1%
Canada 1 <1%
Unknown 237 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 32 13%
Researcher 30 12%
Student > Master 24 10%
Student > Ph. D. Student 21 9%
Other 20 8%
Other 51 21%
Unknown 64 26%
Readers by discipline Count As %
Medicine and Dentistry 104 43%
Pharmacology, Toxicology and Pharmaceutical Science 21 9%
Nursing and Health Professions 10 4%
Psychology 6 2%
Biochemistry, Genetics and Molecular Biology 5 2%
Other 23 10%
Unknown 73 30%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 16. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 October 2020.
All research outputs
#2,277,293
of 25,457,858 outputs
Outputs from Cochrane database of systematic reviews
#4,691
of 11,499 outputs
Outputs of similar age
#12,246
of 191,497 outputs
Outputs of similar age from Cochrane database of systematic reviews
#28
of 112 outputs
Altmetric has tracked 25,457,858 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 91st percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 191,497 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 112 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 75% of its contemporaries.